| PERIOD ENDING | 31-Mar-09 | 31-Mar-08 | 31-Mar-07 | | Total Revenue | 44,861,120 | 47,189,054 | 40,728,930 | | Cost of Revenue | 17,148,704 | 19,643,405 | 16,890,558 | | | Gross Profit | 27,712,416 | 27,545,649 | 23,838,372 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 11,221,059 | 11,674,472 | 10,918,484 | | Non Recurring |
-
|
-
| 10,344 | | Others | 8,110,530 | 7,775,914 | 6,329,721 | | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 8,380,827 | 8,095,263 | 6,579,823 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (462,612) | (30,726) | 43,961 | | Earnings Before Interest And Taxes | 7,918,215 | 8,064,537 | 6,623,784 | | Interest Expense | 46,576 | 45,629 | 48,903 | | Income Before Tax | 7,871,639 | 8,018,908 | 6,574,881 | | Income Tax Expense | 3,110,439 | 3,234,401 | 2,668,246 | | Minority Interest | 4,761 | (841) | (383) | | | | Net Income From Continuing Ops | 4,759,183 | 4,919,399 | 3,889,741 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 4,759,183 | 4,919,399 | 3,889,741 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $4,759,183 | $4,919,399 | $3,889,741 |
|
1.23% Nasdaq 
Income Statement
